Schneeweiss, A., Park-Simon, T., Albanell, J., Lassen, U., Cortés, J., , … Cervantes, A. (2018). Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer. Investigational New Drugs. https://doi.org/10.1007/s10637-018-0562-4 (Original work published 2018)

Martinez-Garcia, M., Salinas-Ortega, M., Estrada-Arriaga, I., Hernández-Lemus, E., García-Herrera, R., & Vallejo, M. A systematic approach to analyze the social determinants of cardiovascular disease. PloS One, 13(1), e0190960. https://doi.org/10.1371/journal.pone.0190960 (Original work published 2018)